Westfield Capital Management CO LP Tg Therapeutics, Inc. Transaction History

Westfield Capital Management CO LP

  • $21.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$7.81 - $20.45 $182,754 - $478,530
-23,400 Closed
0 $0
Q4 2021

Feb 10, 2022
SELL
$15.2 - $35.51 $25 Million - $58.4 Million
-1,643,299 Reduced 98.6%
23,400 $445,000
Q3 2021

Nov 12, 2021
BUY
$21.78 - $40.45 $588,560 - $1.09 Million
27,023 Added 1.65%
1,666,699 $55.5 Million
Q2 2021

Aug 10, 2021
BUY
$32.5 - $48.96 $53.3 Million - $80.3 Million
1,639,676 New
1,639,676 $63.6 Million

Others Institutions Holding TGTX

# of Institutions
354
Shares Held
90.2M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.81B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Westfield Capital Management CO LP Portfolio

Follow Westfield Capital Management CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email